Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europska Unija - hrvatski - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - natrijev ibandronat hidrat - filmom obložena tableta - 150 mg - urbroj: svaka filmom obložena tableta sadrži 150 mg ibandronatne kiseline (u obliku natrijevog ibandronat hidrata)

Europska Unija - hrvatski - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - empagliflozin - diabetes mellitus, type 2; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusjardiance is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered in addition to other medicinal products for the treatment of diabetesfor study results with respect to combinations of therapies, effects on glycaemic control, and cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. of the annex. heart failurejardiance is indicated in adults for the treatment of symptomatic chronic heart failure.  chronic kidney diseasejardiance is indicated in adults for the treatment of chronic kidney disease.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

novartis ba d.o.o. - ibandronska kiselina - filmom obložena tableta - 150 mg/1 tableta - 1 filmom obložena tableta sadrži: 150 mg ibandronat natrija

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb - diazepam - otopina za injekciju - 10 mg/2 ml - urbroj: 2 ml otopine za injekciju (1 ampula) sadrži 10 mg diazepama

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - diazepam - obložena tableta - 2 mg - urbroj: jedna obložena tableta sadrži 2 mg diazepama

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alkaloid d.o.o., slavonska avenija 6 a, zagreb, hrvatska - diazepam - obložena tableta - 5 mg - urbroj: jedna obložena tableta sadrži 5 mg diazepama

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - diazepam - tableta - 10 mg - urbroj: jedna tableta sadrži 10 mg diazepama

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

jadran galenski laboratorij d.d., svilno 20, rijeka, hrvatska - diazepam - tableta - 2 mg - urbroj: jedna tableta sadrži 2 mg diazepama